Q3 2025 AVITA Medical Inc Earnings Call Transcript
Key Points
- All seven Medicare Administrative Contractors (MACs) have published or confirmed acceptance of provider reimbursement rates for RECELL, providing clarity and confidence to clinicians.
- RECELL has been incorporated into treatment protocols at one of the nation's leading burn centers, demonstrating its growing acceptance and integration into clinical practice.
- RECELL GO received CE Mark approval in Europe, with the first patient treated in Germany, expanding the global reach of AVITA Medical Inc (AVHHL)'s technology.
- The company has refined its commercial organization to focus on high-value accounts, improving customer behavior visibility and coordination between sales and clinical teams.
- AVITA Medical Inc (AVHHL) has reduced operating expenses by 24% year over year, reflecting disciplined cost management and a leaner operating structure.
- Third-quarter revenue was $17 million, below expectations, due to reimbursement disruptions and slower-than-anticipated normalization.
- Full-year revenue guidance has been revised down to $70 million to $74 million from the previous $76 million to $81 million.
- Gross profit margin declined to 81.3% from 83.7% in the previous year, impacted by product mix and inventory-related adjustments.
- The company faces challenges with the pace of hospital Value Analysis Committee (VAC) reviews, affecting near-term results.
- Net loss for the quarter was $13.2 million, although improved from the previous year, it still reflects ongoing financial challenges.
Good day, and thank you for standing by. Welcome to the AVITA Medical, Inc. third-quarter 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Ben Atkins. Please go ahead.
Thank you, operator. Welcome to AVITA Medical's third-quarter 2025 earnings call. Joining me on today's call are Cary Vance, Interim Chief Executive Officer; and David O'Toole, Chief Financial Officer. Today's earnings release and presentation are available on our website at www.avitamedical.com under the Investor Relations section.
Before we begin, I would like to remind you that this call includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are neither promises nor guarantees and involve known and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
